Signals, Powered By EquityPandit
Biocon has reported a 47% rise in net profit at Rs.120 crore, for the quarter ended June 30,2018.
The company had reported a net profit of Rs.81 crore in the year-ago period. Total revenue for the quarter under review rose 21% to Rs.1,192 crore in the quarter. The gross spending on research and development fell 8% to Rs.88 crore on YoY basis.
Furthermore, the earnings before interest, tax, depreciation, and amortization (EBITDA) stood at 26% for Q1FY19, while in the same period last year it was 25%.
